Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1

Conditions

Thrombocytopenia 7Carcinoma, Hepatocellular 2Neoplasms 1Lymphoma 1Liver Diseases 1Chemotherapy-induced Thrombocytopenia 1

Interventions

Cyclophosphamide 37fludarabine phosphate 31Busulfan 25Antilymphocyte Serum 22Mycophenolic Acid 20Melphalan 19Cyclosporine 19Peripheral Blood Stem Cell Transplantation 16Filgrastim 16Cord Blood Stem Cell Transplantation 16Whole-Body Irradiation 14Tacrolimus 14Radiotherapy 14Methylprednisolone 13fludarabine 11Methotrexate 8Epoetin Alfa 8Etoposide 7Cytarabine 7Thiotepa 6Alemtuzumab 6thymoglobulin 4Granulocyte Colony-Stimulating Factor 4Darbepoetin alfa 3Bone Marrow Transplantation 3Stem Cell Transplantation 2Sirolimus 2Rituximab 2Mesna 2Influenza Vaccines 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × avatrombopag × Classical hematology × Clear all
NCT04797182 2021-03-15

Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma

Sun Yat-sen University

Phase 2 Unknown
46 enrolled
Classical hematologyLymphoid

Lymphoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡